Real-World Treatment Patterns, Healthcare Resource Utilization, Costs, and Survival Among Medicare Beneficiaries with Diffuse Large B-Cell Lymphoma (DLBCL)

被引：1
|
作者：
Garg, Mahek [1 ]
Huntington, Scott F. [2 ]
Puckett, Justin [3 ]
Kamal-Bahl, Sachin [4 ]
Raut, Monika [1 ]
Ryland, Katherine Elizabeth [5 ]
Doshi, Jalpa [6 ]
机构：
[1] Merck & Co Inc, Ctr Observat & Real World Evidence, Rahway, NJ USA
[2] Yale Univ, Dept Internal Med, Sect Hematol, Sch Med, New Haven, CT USA
[3] COVIA Hlth Solut, Philadelphia, PA USA
[4] COVIA Hlth Solut, Lansdale, PA USA
[5] Merck & Co Inc, Kenilworth, NJ USA
[6] Univ Penn, Perelman Sch Med, Div Gen Internal Med, Philadelphia, PA USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-158026
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：10814 / 10815
页数：2
相关论文
共 50 条
  • [41] Real-world treatment patterns, health care resource utilization, and costs in a US Medicare population with bronchiectasis
    Tkacz, Joseph
    Lewing, Benjamin
    Feliciano, Joseph
    Mohanty, Maitreyee
    Lauterio, Melanie
    Fucile, Sebastian
    Barker, Alan
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (09): : 967 - 977
  • [42] Real-World Effectiveness of Tafasitamab (Tafa) for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) in the United States
    Saverno, Kimberly
    Nastoupil, Loretta
    Feinberg, Bruce
    Galvin, John
    Pathak, Prathamesh
    Amoloja, Theresa
    Gentile, Danielle
    Asgarisabet, Parisa
    Epperla, Narendranath
    BLOOD, 2024, 144 : 2375 - 2376
  • [43] Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort
    Ghesquieres, Herve
    Cherblanc, Fanny
    Belot, Aurelien
    Micon, Sophie
    Bouabdallah, Krimo K.
    Esnault, Cyril
    Fornecker, Luc-Matthieu
    Thokagevistk, Katia
    Bonjour, Maxime
    Bijou, Fontanet
    Haioun, Corinne
    Morineau, Nadine
    Ysebaert, Loic
    Damaj, Gandhi
    Tessoulin, Benoit
    Guidez, Stephanie
    Morschhauser, Franck
    Thieblemont, Catherine
    Chauchet, Adrien
    Gressin, Remy
    Jardin, Fabrice
    Fruchart, Christophe
    Laboure, Gaelle
    Fouillet, Ludovic
    Lionne-Huyghe, Pauline
    Bonnet, Antoine
    Lebras, Laure
    Amorim, Sandy
    Leyronnas, Cecile
    Olivier, Gaelle
    Guieze, Romain
    Houot, Roch
    Launay, Vincent
    Drenou, Bernard
    Fitoussi, Olivier
    Detourmignies, Laurence
    Abraham, Julie
    Soussain, Carole
    Lachenal, Florence
    Pica, Gian Matteo
    Fogarty, Patrick
    Cony-Makhoul, Pascale
    Bernier, Adeline
    Le Guyader-Peyrou, Sandra
    Monnereau, Alain
    Boissard, Frederic
    Rossi, Cedric
    Camus, Vincent
    BLOOD ADVANCES, 2024, 8 (02) : 296 - 308
  • [44] Cost and Healthcare Utilization in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Real-World Analysis of Medicare Beneficiaries Receiving Chimeric Antigen Receptor T-Cell Vs. Autologous and Allogeneic Hematopoietic Cell Transplants
    Mohammadi, Iman
    Purdum, Anna G.
    Wong, Anny C.
    Schroeder, Amy
    Kilgore, Karl M.
    Shah, Gunjan L.
    BLOOD, 2020, 136
  • [45] Association of race/ethnicity and insurance with survival in patients with diffuse large B-cell lymphoma in a large real-world cohort
    Jin, Yanling
    Li, Jia
    Mun, Yong
    Masaquel, Anthony
    Hu, Sylvia
    Biondo, Juliana M. L.
    CANCER MEDICINE, 2024, 13 (16):
  • [46] Real-world demographic and clinical characteristics of patients diagnosed with diffuse large B-cell lymphoma (DLBCL) in the United States (US).
    Yang, Xiaoqin
    Laliberte, Francois
    Germain, Guillaume
    Raut, Monika Kumar
    Duh, Mei Sheng
    Sen, Shuvayu
    Lejeune, Dominique
    Cavanaugh, Cristi
    Desai, Kaushal
    Armand, Phillippe
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] Real-World Treatment Patterns and Overall Survival Among Medicare Fee-for-Service Beneficiaries Newly Diagnosed with Peripheral T-Cell Lymphoma
    Shah, Anne
    Petrilla, Allison
    Rebeira, Mayvis
    Feliciano, Joseph
    LeBlanc, Thomas W.
    Lisano, Julie
    BLOOD, 2019, 134
  • [48] Management of Canadian Patients (Pts) with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) in the Real-World
    Peters, Anthea
    Nowakowski, Grzegorz S.
    Dabas, Rosy
    Amoloja, Theresa
    Xue, Zhenyi
    Koch, Caroline
    Waltl, Eva E.
    Fleury, Isabelle
    BLOOD, 2022, 140 : 3811 - 3813
  • [49] REAL-WORLD TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION, AND COSTS AMONG PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION IN THE UNITED STATES
    Pizzicato, Lia
    Nadipelli, Vijay R.
    Samuel, Governor
    Mao, Jianbin
    Lanes, Stephan
    Butler, John
    Pepe, Rebecca S.
    Phatak, Hemant
    El-Kersh, Karim
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1677 - 1677
  • [50] Real-World Challenges of Managing Diffuse Large B-Cell Lymphoma in a Developing Country
    Iftikhar, Raheel
    Ahmad, Usman
    Haider, Ghulam
    Mahmood, Humera
    Khan, Maryam
    Masood, Misbah
    Anwar, Nida
    Javed, Qamar
    Sajid, Nadia
    Tariq, Rija
    Mehmod, Sana
    Haider, Javeria
    Abro, Nargis Aalam
    Shahbaz, Shanzah
    Khokhar, Abbas
    Khan, Zeeshan Ahmed
    Pervez, Hassan
    Moosajee, Munira
    Aziz, Zeba
    JCO GLOBAL ONCOLOGY, 2024, 10
12345